6th Annual Clinical Outcome Assessment in Cancer Clinical Trials Workshop: Characterizing Physical Function - Day One

Panelists will discuss the importance of measuring physical function in cancer trials, trial design considerations to detect changes in this concept, and existing instruments used for measurement.

• FDA, The Food and Drug Administration

• Player Requirements
• Live Captioning
• FDA OCE PFDD Main Page
• FDA OCE Project Patient Voice Main Page
• FDA May 2021 ODAC Event Page
• FDA PRO in CCT Draft Guidance for Industry
• 2021 COA-CCT Workshop Event Page
• 2020 COA-CCT Workshop Event Page
• 2019 COA-CCT Workshop Event Page
• 2018 COA-CCT Workshop Event Page
• 2017 COA-CCT Workshop Event Page
• 2016 COA-CCT Workshop Event Page